drugset / Trial / NCT00004182
Irinotecan in Treating Patients With Metastatic or Recurrent Breast Cancer
Treatment
Summary
RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. PURPOSE: Phase II trial to study the effectiveness of irinotecan in treating patients who have metastatic or recurrent breast cancer.
Timeline
- Start
- 1999-10
- Primary completion
- 2000-04
- Completion
- 2000-04
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Irinotecan | Small molecule | — | Intravenous |